Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V C Jordan

Showing results (91-100 of 365) with videos related to

Pageof 37
Sort By:
Annals of Surgical Oncology|February 16, 2000
Tamoxifen for the prevention of breast cancer in the high-risk womanM Morrow, V C Jordan
The Journal of Endocrinology|March 1, 1976
Tamoxifen as an anti-tumour agent: oestrogen binding as a predictive test for tumour responseV C Jordan, T Jaspan
Journal of Steroid Biochemistry|September 1, 1983
Differential antiestrogen action in the immature rat uterus: a comparison of hydroxylated antiestrogens with high affinity for the estrogen receptorV C Jordan, B Gosden
Breast Cancer Research and Treatment|January 1, 1994
What do we know and what don't we know about tamoxifen in the human uterusA Friedl, V C Jordan
Surgical Oncology Clinics of North America|October 1, 1995
Hormonal treatment of advanced breast cancerC Tellez, V C Jordan
Prostaglandins|August 1, 1976
Considerations into the mechanism of estrogen-stimulated uterine prostaglandin synthesisV D Castracane, V C Jordan
Molecular Pharmacology|September 1, 1984
Estrogen-stimulated prolactin synthesis in vitro. Classification of agonist, partial agonist, and antagonist actions based on structureV C Jordan, M E Lieberman
European Journal of Cancer & Clinical Oncology|December 1, 1987
Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) cultureW V Welshons, V C Jordan
Receptor|January 1, 1990
The biological significance of the interaction of estrogen agonists and antagonists with the estrogen receptorC S Murphy, V C Jordan
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Selective oestrogen receptor modulation: molecular pharmacology for the millenniumA S Levenson, V C Jordan
Pageof 37

Showing results (91-100 of 365) with videos related to

Sort By:
Pageof 37
Annals of Surgical Oncology|February 16, 2000
Tamoxifen for the prevention of breast cancer in the high-risk womanM Morrow, V C Jordan
The Journal of Endocrinology|March 1, 1976
Tamoxifen as an anti-tumour agent: oestrogen binding as a predictive test for tumour responseV C Jordan, T Jaspan
Journal of Steroid Biochemistry|September 1, 1983
Differential antiestrogen action in the immature rat uterus: a comparison of hydroxylated antiestrogens with high affinity for the estrogen receptorV C Jordan, B Gosden
Breast Cancer Research and Treatment|January 1, 1994
What do we know and what don't we know about tamoxifen in the human uterusA Friedl, V C Jordan
Surgical Oncology Clinics of North America|October 1, 1995
Hormonal treatment of advanced breast cancerC Tellez, V C Jordan
Prostaglandins|August 1, 1976
Considerations into the mechanism of estrogen-stimulated uterine prostaglandin synthesisV D Castracane, V C Jordan
Molecular Pharmacology|September 1, 1984
Estrogen-stimulated prolactin synthesis in vitro. Classification of agonist, partial agonist, and antagonist actions based on structureV C Jordan, M E Lieberman
European Journal of Cancer & Clinical Oncology|December 1, 1987
Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) cultureW V Welshons, V C Jordan
Receptor|January 1, 1990
The biological significance of the interaction of estrogen agonists and antagonists with the estrogen receptorC S Murphy, V C Jordan
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Selective oestrogen receptor modulation: molecular pharmacology for the millenniumA S Levenson, V C Jordan
Pageof 37